SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 44.72 |
| Enterprise Value ($M) | 5.70 |
| Book Value ($M) | -12.74 |
| Book Value / Share | -0.46 |
| Price / Book | -3.51 |
| NCAV ($M) | -53.55 |
| NCAV / Share | -1.94 |
| Price / NCAV | -0.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.83 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -30.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.06 |
| Current Ratio | 1.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 86.28 |
| Assets | 127.08 |
| Liabilities | 139.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Highbridge Capital Management Llc | 9.00 | ||
| 13D/A | Rosenwald Lindsay A Md | 18.40 | 85.68 | |
| 13G/A | Nantahala Capital Management, LLC | 4.20 | -95.32 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 99,814 | 257,613 | 38.75 | |
| 121,860 | 314,642 | 38.73 | |
| 68,648 | 219,920 | 31.21 | |
| 127,912 | 356,778 | 35.85 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ESLA – Estrella Immunopharma, Inc. | EVOK – Evoke Pharma, Inc. |
| EYEN – Eyenovia, Inc. | FBRX – Forte Biosciences, Inc. |
| FENC – Fennec Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io